WHO Pediatric Praziquantel Stakeholders Meeting
11 December 2018
WHO HQ, Geneva, Switzerland
The meeting will discuss phase II results of the Oral Dispersible Tablet (ODT) for praziquantel and look at resource mobilization required for the procurement and deployment of the ODTs to treat young children.
Implementation Control and Elimination